Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial
| Image |  |
|---|---|
| Description | scientific article published on 19 July 2019 |
| Author/s |
author: Ghazaleh Tabatabai Claus Belka Elke Hattingen Sied Kebir |
| Publication date | July 19, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |